Overview

Observational Study of Oralair® in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis With/Without Conjunctivitis

Status:
Completed
Trial end date:
2017-07-03
Target enrollment:
Participant gender:
Summary
Safety and tolerability of ORALAIR in children 5 to 9 years of age during the first 30 days of treatment.
Details
Lead Sponsor:
Stallergenes
Stallergenes Greer
Collaborator:
Venn Life Sciences